Page 26 - Monash University

Oncology & Cancer

Global trial reveals life saving drug for acute myeloid leukemia

A landmark paper published today in the New England Journal of Medicine describes the results from a global trial across 148 sites in 23 countries, showing a 30 percent improvement in survival in patients with acute myeloid ...

Diseases, Conditions, Syndromes

COVID immunity lasts at least eight months, new data reveals

Australian researchers have revealed—for the first time—that people who have been infected with the COVID-19 virus have immune memory to protect against reinfection for at least eight months.

Medical research

Researchers expose power of enzyme on key immune cells

Communication, serendipity and an enzyme called DOT1L have all combined to produce some exciting findings into the immune system's B cells and T cells by two groups of Monash Biomedicine Discovery Institute (BDI) scientists. ...

Diseases, Conditions, Syndromes

Way forward in protecting healthcare workers from COVID-19

A new study by Monash University provides evidence that a simple ventilated headboard hood can stop the spread of SARS-CoV2 between patients and health care workers in hospital wards.

Oncology & Cancer

Discoveries suggest new breast cancer treatment

Findings by Monash Biomedicine Discovery Institute (BDI) researchers have pointed to a new combination of treatments that may help breast cancer patients with certain gene mutations.

Cardiology

A first-in-class antibody designed to prevent clotting

Researchers from Monash University have designed a novel antibody that inhibits one particular blood-borne protein to prevent clot formation, or thrombosis, without potential adverse side effects.

Oncology & Cancer

New targets for melanoma treatment

A collaborative study led by Monash University's Biomedicine Discovery Institute and the Olivia Newton-John Cancer Research Institute (ONJCRI) has uncovered new markers (HLA-associated peptides) that are uniquely present ...

page 26 from 40